Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

The Orphan Drug designation is supported by positive preclinical data from bleomycin-induced mouse models and patient-derived skin fibroblasts.

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

Crohn's disease—an autoimmune disorder—is characterized by chronic inflammation of the digestive tract, resulting in a slew ...

CereVasc shared data from a study demonstrating that its eShunt system may help deliver gene therapies to the central nervous ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

NanoViricides, Inc. (NYSE American.:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that it has now obtained a right of first refusal ...